Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same author

Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease.

RSC medicinal chemistry·2026
Same author

Anionic Supramolecular Cluster with [Cu<sub>4</sub>Br<sub>7</sub>O]<sup>2-</sup> Core: Self-Assembly and Photocatalysis for Organic Transformations.

Inorganic chemistry·2025
Same author

Qifenggubiao granules attenuate LPS-induced inflammation through α7nAChR activation: An integrated study of network pharmacology and phytopharmacological validation.

Fitoterapia·2025
Same author

The Mortality Risk of Acute Kidney Injury Stage 1A and 1B in Cirrhosis: A Systematic Review and Meta-Analysis.

Journal of clinical and experimental hepatology·2025
Same author

Role of the transcription factor <i>SOX8</i> in hepatocellular carcinoma development and lymph node metastasis.

Translational cancer research·2025

Related Experiment Video

Updated: May 7, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Novel oncoprotein EPS8: a new target for anticancer therapy.

Yu-Hua Li1, Tong-Yuan Xue, Ying-Zhi He

  • 1Department of Hematology, Zhujiang Hospital, Southern Medical University, 510282 Guangzhou, China.

Future Oncology (London, England)
|October 11, 2013
PubMed
Summary

The EPS8 protein is overexpressed in many cancers and drives tumor growth and spread. Targeting EPS8 may offer a new therapeutic strategy for cancer treatment.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.7K

Related Experiment Videos

Last Updated: May 7, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) substrate 8 (EPS8) is a tyrosine kinase substrate involved in EGFR-mediated mitogenic signaling.
  • EPS8 is frequently overexpressed in various cancers, including breast, colon, and cervical cancers, as well as hematologic malignancies.
  • Its involvement in key cellular processes like tumorigenesis, proliferation, migration, and metastasis highlights its significance in cancer progression.

Purpose of the Study:

  • To provide a comprehensive overview of EPS8's role in cellular functions.
  • To elucidate the significance of EPS8 in tumorigenesis.
  • To explore the potential of EPS8 as a therapeutic target for cancer.

Main Methods:

  • Literature review of existing research on EPS8.
  • Analysis of signaling pathways involving EPS8.
  • Evaluation of EPS8's role in cancer progression and prognosis.

Main Results:

  • EPS8 overexpression is linked to poor prognosis in cancer patients.
  • EPS8 participates in multiple signaling pathways crucial for cancer development.
  • EPS8's functions extend to cell proliferation, migration, and metastasis.

Conclusions:

  • EPS8 plays a critical role in various cellular processes relevant to cancer.
  • The overexpression and functional significance of EPS8 position it as a potential therapeutic target.
  • Targeting EPS8 may represent a promising strategy for cancer therapy.